Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.84	54.62	-67.30
Graham Fair Price	42.46	33.83	23.75
PEG	-71.08	0.22	-0.75
Price/Book	1.32	3.86	3.81
Price/Cash Flow	-43.57	73.78	130.75
Prices/Earnings	-49.43	22.04	43.58
Price/Sales	-6.11	3.68	3.91
Price/FCF	-43.57	73.78	130.75
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.33	0.12	0.11
Operating Margin	55.95	0.07	0.05
ROA	99.84	0.01	< 0.005
ROE	0.02	0.04	100.35
ROIC	0.02	0.03	67.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.06	80.68
Dividends QOQ	< 0.005	0.08	3856.26
EBIT QOQ	-0.45	0.66	47.07
EPS QOQ	-0.58	1.01	74.88
FCF QOQ	-0.46	0.77	65.81
Revenue QOQ	-0.08	0.06	-24.05
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.17	0.00	inf
Days Sales Outstanding (DSO)	47.36	45.51	-3.90
Inventory Turnover	515.00	0.00	inf
Debt/Capitalization	0.56	0.56	0.11
Quick Ratio	0.87	0.85	-2.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	33.87	34.09	0.64
Cash	1.78	0.95	-46.76
Capex	-0.21	-0.12	44.29
Free Cash Flow	0.99	1.78	80.69
Revenue	32.96	35.79	8.60
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.98	0.95	-3.20
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-16.18	13.23	-18.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating